Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


15.04.2019

1 Am J Transl Res
2 Anticancer Res
1 Artif Cells Nanomed Biotechnol
1 Asian J Surg
1 Asian Pac J Cancer Prev
1 Biol Aujourdhui
1 Biol Open
1 Biol Trace Elem Res
1 Biomed Pharmacother
1 BMC Cancer
1 Cancer Med
1 Clin Cancer Res
1 Clin Lab
1 Curr Urol Rep
1 Emerg Infect Dis
1 Eur Rev Med Pharmacol Sci
3 Eur Urol
5 Eur Urol Focus
1 Expert Rev Mol Diagn
1 Future Oncol
1 Histochem Cell Biol
1 Hum Pathol
1 Int J Mol Sci
1 J Am Vet Med Assoc
1 J Cell Biochem
1 J Cell Physiol
1 J Obstet Gynaecol India
1 J Vet Med Sci
1 Minerva Urol Nefrol
1 Nanoscale
1 Nutr Cancer
1 Open Access Maced J Med Sci
1 Polymers (Basel)
2 Prog Urol
1 Sci Rep
12 Transl Androl Urol
1 Urol J
1 Virchows Arch


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Transl Res

  1. JIANG Y, Wei T, Li W, Zhang R, et al
    Circular RNA hsa_circ_0002024 suppresses cell proliferation, migration, and invasion in bladder cancer by sponging miR-197-3p.
    Am J Transl Res. 2019;11:1644-1652.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. HANADA E, Kageyama S, Murai R, Kubota S, et al
    Pro-GA, a Novel Inhibitor of gamma-Glutamylcyclotransferase, Suppresses Human Bladder Cancer Cell Growth.
    Anticancer Res. 2019;39:1893-1898.
    PubMed     Text format     Abstract available

  3. HUANG AC, Cheng YD, Huang LH, Hsiao YT, et al
    Casticin Induces DNA Damage and Impairs DNA Repair in Human Bladder Cancer TSGH-8301 Cells.
    Anticancer Res. 2019;39:1839-1847.
    PubMed     Text format     Abstract available


    Artif Cells Nanomed Biotechnol

  4. SUN J, Zhang H, Tao D, Xie F, et al
    CircCDYL inhibits the expression of C-MYC to suppress cell growth and migration in bladder cancer.
    Artif Cells Nanomed Biotechnol. 2019;47:1349-1356.
    PubMed     Text format     Abstract available


    Asian J Surg

  5. KIM TN, Chung MK, Nam JK, Lee JZ, et al
    Effectiveness of hyaluronic acid/carboxymethylcellulose in preventing adhesive bowel obstruction after laparoscopic radical cystectomy.
    Asian J Surg. 2019;42:394-400.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  6. TANAKA Y, Okamura T, Chaya R, Nagai T, et al
    Outcomes and Complications of Simultaneous Laparoscopic Cystectomy and Laparoscopic Nephroureterectomy with Umbilical Reduced Port Surgery
    Asian Pac J Cancer Prev. 2018;19:3495-3500.
    PubMed     Text format     Abstract available


    Biol Aujourdhui

  7. LENFANT L, Roupret M
    [Immunotherapy and bladder cancer].
    Biol Aujourdhui. 2018;212.
    PubMed     Text format     Abstract available


    Biol Open

  8. CHENG XZ, Zhou HL, Tang SX, Jiang T, et al
    Intercellular transfer of P-glycoprotein mediates the formation of stable multidrug resistance in human bladder cancer BIU-87 cells.
    Biol Open. 2019 Apr 9. pii: bio.041889. doi: 10.1242/bio.041889.
    PubMed     Text format     Abstract available


    Biol Trace Elem Res

  9. MORTADA WI, Abdelghany AM
    Preconcentration of Lead in Blood and Urine Samples Among Bladder Cancer Patients Using Mesoporous Strontium Titanate Nanoparticles.
    Biol Trace Elem Res. 2019 Apr 10. pii: 10.1007/s12011-019-01704.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  10. JIANG F, Qi W, Wang Y, Wang W, et al
    lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer.
    Biomed Pharmacother. 2019;114:108814.
    PubMed     Text format     Abstract available


    BMC Cancer

  11. YASUI M, Kawahara T, Izumi K, Yao M, et al
    Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer.
    BMC Cancer. 2019;19:331.
    PubMed     Text format     Abstract available


    Cancer Med

  12. BUNCH BL, Ma Y, Attwood K, Amable L, et al
    Vitamin D3 enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk.
    Cancer Med. 2019 Apr 10. doi: 10.1002/cam4.2119.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  13. BATISTA DA COSTA J, Gibb EA, Bivalacqua TJ, Liu Y, et al
    Molecular characterization of neuroendocrine-like bladder cancer.
    Clin Cancer Res. 2019 Apr 5. pii: 1078-0432.CCR-18-3558.
    PubMed     Text format     Abstract available


    Clin Lab

  14. BAYKAN O, Akgul M, Uren N, Yaman A, et al
    The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.
    Clin Lab. 2019;65.
    PubMed     Text format     Abstract available


    Curr Urol Rep

  15. PEARCE S, Daneshmand S
    Correction to: Enhanced Endoscopy in Bladder Cancer.
    Curr Urol Rep. 2019;20:25.
    PubMed     Text format     Abstract available


    Emerg Infect Dis

  16. GOEL R, Westblade LF, Kessler DA, Sfeir M, et al
    Death from Transfusion-Transmitted Anaplasmosis, New York, USA, 2017.
    Emerg Infect Dis. 2018;24:1548-1550.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  17. LIU XK, Chen D, Li X
    MiR-335 suppresses cell proliferation and migration by upregulating CRKL in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2019;23:2399-2408.
    PubMed     Text format     Abstract available


    Eur Urol

  18. GUST KM, Shariat SF
    Re: Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Carcinoma (PURE-01): An Open-label, Single-arm, Phase II Study.
    Eur Urol. 2019;75:695-696.
    PubMed     Text format    

  19. LERNER SP, Svatek RS
    What is the Standard of Care for Pelvic Lymphadenectomy Performed at the Time of Radical Cystectomy?
    Eur Urol. 2019;75:612-614.
    PubMed     Text format    

  20. SHI MJ, Meng XY, Lamy P, Banday AR, et al
    APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer.
    Eur Urol. 2019 Apr 8. pii: S0302-2838(19)30261.
    PubMed     Text format     Abstract available


    Eur Urol Focus

  21. BURGER M
    Hexvix plus Chemo.
    Eur Urol Focus. 2018;4:468-469.
    PubMed     Text format     Abstract available

  22. O'BRIEN T
    The Case for Photodynamic Diagnosis-assisted Resection Without Intravesical Single-shot Chemotherapy.
    Eur Urol Focus. 2018;4:470-471.
    PubMed     Text format     Abstract available

  23. RENTSCH CA, Derre L, Dugas SG, Wetterauer C, et al
    Building on a Solid Foundation: Enhancing Bacillus Calmette-Guerin Therapy.
    Eur Urol Focus. 2018;4:485-493.
    PubMed     Text format     Abstract available

  24. MATHES J, Todenhofer T
    Managing Toxicity of Intravesical Therapy.
    Eur Urol Focus. 2018;4:464-467.
    PubMed     Text format     Abstract available

  25. BANDARI J, Maganty A, MacLeod LC, Davies BJ, et al
    Manufacturing and the Market: Rationalizing the Shortage of Bacillus Calmette-Guerin.
    Eur Urol Focus. 2018;4:481-484.
    PubMed     Text format     Abstract available


    Expert Rev Mol Diagn

  26. CIMADAMORE A, Gasparrini S, Santoni M, Cheng L, et al
    Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer.
    Expert Rev Mol Diagn. 2018;18:645-655.
    PubMed     Text format     Abstract available


    Future Oncol

  27. HINDY JR, Souaid T, Kourie HR, Kattan J, et al
    Targeted therapies in urothelial bladder cancer: a disappointing past preceding a bright future?
    Future Oncol. 2019 Apr 12. doi: 10.2217/fon-2018-0459.
    PubMed     Text format     Abstract available


    Histochem Cell Biol

  28. ERMAN A, Kapun G, Novak S, Pavlin M, et al
    How cancer cells attach to urinary bladder epithelium in vivo: study of the early stages of tumorigenesis in an orthotopic mouse bladder tumor model.
    Histochem Cell Biol. 2019;151:263-273.
    PubMed     Text format     Abstract available


    Hum Pathol

  29. ISHARWAL S, Huang H, Nanjangud G, Audenet F, et al
    Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma.
    Hum Pathol. 2018;77:63-69.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  30. FERREIRA R, Neuparth MJ, Nogueira-Ferreira R, Magalhaes S, et al
    Exercise Training Impacts Cardiac Mitochondrial Proteome Remodeling in Murine Urothelial Carcinoma.
    Int J Mol Sci. 2018;20.
    PubMed     Text format     Abstract available


    J Am Vet Med Assoc

  31. ST BLANC A, Crossland NA, DiGeronimo PM, Cianciolo RE, et al
    Pathology in Practice.
    J Am Vet Med Assoc. 2018;253:53-56.
    PubMed     Text format    


    J Cell Biochem

  32. YE X, Guo J, Zhang H, Meng Q, et al
    The enhanced expression of estrogen-related receptor alpha in human bladder cancer tissues and the effects of estrogen-related receptor alpha knockdown on bladder cancer cells.
    J Cell Biochem. 2019 Apr 11. doi: 10.1002/jcb.28657.
    PubMed     Text format     Abstract available


    J Cell Physiol

  33. YANG Z, Liu A, Xiong Q, Xue Y, et al
    Prognostic value of differentially methylated gene profiles in bladder cancer.
    J Cell Physiol. 2019 Apr 5. doi: 10.1002/jcp.28515.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol India

  34. TYAGI S, Nelivigi G, Bhagat S
    Management of Bladder Cancer in the Second Trimester of Pregnancy.
    J Obstet Gynaecol India. 2019;69.
    PubMed     Text format    


    J Vet Med Sci

  35. OKAMOTO M, Soeda T, Asamura A, Tanaka K, et al
    Functional comparison of the human epidermal growth factor receptor and telomerase reverse transcriptase promoters in canine tumor cells.
    J Vet Med Sci. 2019;81:397-400.
    PubMed     Text format     Abstract available


    Minerva Urol Nefrol

  36. MOSCHINI M, Zamboni S, Mattei A, Amparore D, et al
    Bacillus Calmette-Guerin unresponsiveness in non-muscle-invasive bladder cancer patients: what the urologists should know.
    Minerva Urol Nefrol. 2019;71:17-30.
    PubMed     Text format     Abstract available


    Nanoscale

  37. WANG J, Li J, Yan G, Gao M, et al
    Preparation of a thickness-controlled Mg-MOFs-based magnetic graphene composite as a novel hydrophilic matrix for the effective identification of the glycopeptide in the human urine.
    Nanoscale. 2019;11:3701-3709.
    PubMed     Text format     Abstract available


    Nutr Cancer

  38. SHIVAPPA N, Hebert JR, Mirsafa F, Rashidkhani B, et al
    Increased Inflammatory Potential of Diet Is Associated with Increased Risk of Bladder Cancer in an Iranian Case-Control Study.
    Nutr Cancer. 2019 Apr 9:1-8. doi: 10.1080/01635581.2019.1597902.
    PubMed     Text format     Abstract available


    Open Access Maced J Med Sci

  39. WISHAHI M, Ismail MA, Elganzoury H, Elkholy A, et al
    Genital-Sparing Cystectomy versus Standard Urethral-Sparing Cystectomy Followed with Orthotopic Neobladder in Women with Bladder Cancer: Incidence and Causes of Hypercontinence with an Ultrastructure Study of Urethral Smooth Muscles.
    Open Access Maced J Med Sci. 2019;7:978-981.
    PubMed     Text format     Abstract available


    Polymers (Basel)

  40. ERMAN A, Veranic P
    The Use of Polymer Chitosan in Intravesical Treatment of Urinary Bladder Cancer and Infections.
    Polymers (Basel). 2018;10.
    PubMed     Text format     Abstract available


    Prog Urol

  41. ALBISINNI S, Moussa I, Aoun F, Quackels T, et al
    The impact of postoperative inflammatory biomarkers on oncologic outcomes of bladder cancer.
    Prog Urol. 2019 Apr 3. pii: S1166-7087(19)30043.
    PubMed     Text format     Abstract available

  42. MOUDOUNI SM, Latabi A, Mouaad A, Lakmichi MA, et al
    [Evaluation of the learning curve of laparoscopic radical cystectomy for cancer: Morbidity and oncological results].
    Prog Urol. 2019;29:50-62.
    PubMed     Text format     Abstract available


    Sci Rep

  43. DI MARTINO E, Alder O, Hurst CD, Knowles MA, et al
    ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer.
    Sci Rep. 2019;9:5740.
    PubMed     Text format     Abstract available


    Transl Androl Urol

  44. MARCQ G, Henon F, Ouzaid I, Fantoni JC, et al
    Active surveillance for non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:54-60.
    PubMed     Text format     Abstract available

  45. BILSKI K, Zapala L, Skrzypczyk MA, Oszczudlowski M, et al
    Review on gender differences in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:12-20.
    PubMed     Text format     Abstract available

  46. MOSCHINI M, Roghmann F, Xylinas E
    The present and future of non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:1.
    PubMed     Text format    

  47. CUMBERBATCH MGK, Noon AP
    Epidemiology, aetiology and screening of bladder cancer.
    Transl Androl Urol. 2019;8:5-11.
    PubMed     Text format     Abstract available

  48. BAUMEISTER P, Zamboni S, Mattei A, Antonelli A, et al
    Histological variants in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:34-38.
    PubMed     Text format     Abstract available

  49. D'ANDREA D, Gontero P, Shariat SF, Soria F, et al
    Intravesical bacillus Calmette-Guerin for bladder cancer: are all the strains equal?
    Transl Androl Urol. 2019;8:85-93.
    PubMed     Text format     Abstract available

  50. ZAMBONI S, Moschini M, Simeone C, Antonelli A, et al
    Prediction tools in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:39-45.
    PubMed     Text format     Abstract available

  51. SORIA F, Marra G, D'Andrea D, Gontero P, et al
    The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer.
    Transl Androl Urol. 2019;8:46-53.
    PubMed     Text format     Abstract available

  52. RINK M, Schwarzenbach H, Vetterlein MW, Riethdorf S, et al
    The current role of circulating biomarkers in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:61-75.
    PubMed     Text format     Abstract available

  53. ZAMBONI S, Baumeister P, Mattei A, Mordasini L, et al
    Single postoperative instillation for non-muscle invasive bladder cancer: are there still any indication?
    Transl Androl Urol. 2019;8:76-84.
    PubMed     Text format     Abstract available

  54. PANG KH, Noon AP
    Selection of patients and benefit of immediate radical cystectomy for non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:101-107.
    PubMed     Text format     Abstract available

  55. HENDRICKSEN K
    Device-assisted intravesical therapy for non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:94-100.
    PubMed     Text format     Abstract available


    Urol J

  56. MIYAKE M, Owari T, Tomizawa M, Matsui M, et al
    Long-term Changes in Renal Function, Blood Electrolyte Levels, and Nutritional Indices after Radical Cystectomy and Ileal Conduit in Patients with Bladder Cancer.
    Urol J. 2019 Apr 7. pii: 4531/1360. doi: 10.22037/uj.v0i0.4531.
    PubMed     Text format     Abstract available


    Virchows Arch

  57. WANG G, Zhou C, Conklin C, Hayes MM, et al
    Metastatic breast carcinoma to the urinary bladder-a report of 11 cases including a tumor to tumor metastasis.
    Virchows Arch. 2019;474:333-339.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: